Accuray (ARAY) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.49% |
| Dec 31, 2025 | 1.07% |
| Sep 30, 2025 | 9.60% |
| Jun 30, 2025 | 15.13% |
| Mar 31, 2025 | 17.52% |
| Dec 31, 2024 | -2.07% |
| Sep 30, 2024 | -0.40% |
| Jun 30, 2024 | -13.16% |
| Mar 31, 2024 | 6.41% |
| Dec 31, 2023 | -15.07% |
| Sep 30, 2023 | -8.93% |
| Jun 30, 2023 | -5.53% |
| Mar 31, 2023 | 14.41% |
| Dec 31, 2022 | -2.60% |
| Sep 30, 2022 | 4.67% |
| Jun 30, 2022 | 2.17% |
| Mar 31, 2022 | -13.77% |
| Dec 31, 2021 | 3.39% |
| Sep 30, 2021 | -0.96% |
| Jun 30, 2021 | 12.28% |
| Mar 31, 2021 | -13.02% |
| Dec 31, 2020 | 16.56% |
| Sep 30, 2020 | 11.50% |
| Jun 30, 2020 | 11.00% |
| Mar 31, 2020 | -20.98% |
| Dec 31, 2019 | 6.28% |
| Sep 30, 2019 | -8.43% |
| Jun 30, 2019 | -5.80% |
| Mar 31, 2019 | -8.58% |
| Dec 31, 2018 | -8.82% |
| Sep 30, 2018 | -9.77% |
| Jun 30, 2018 | -13.74% |
| Mar 31, 2018 | -16.34% |
| Dec 31, 2017 | -13.53% |
| Sep 30, 2017 | -15.45% |
| Jun 30, 2017 | -22.13% |
| Mar 31, 2017 | -22.01% |
| Dec 31, 2016 | -21.15% |
| Sep 30, 2016 | -17.39% |
| Jun 30, 2016 | -48.01% |
| Mar 31, 2016 | -20.06% |
| Dec 31, 2015 | -26.10% |
| Sep 30, 2015 | -28.16% |
| Jun 30, 2015 | -28.10% |
| Mar 31, 2015 | -28.72% |
| Dec 31, 2014 | -30.30% |
| Sep 30, 2014 | -30.43% |
| Jun 30, 2014 | -25.71% |
| Jun 30, 2013 | 35.65% |